The story of Evelyne, as told by her mom, Tiffany
Type: Parent Stories
Topic(s): 28-32 weeks (very premature)
Prolacta Bioscience reassures hospitals of the safety of its human milk-based nutritional products during the coronavirus pandemic
Type: Press Releases
Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Pasteurization Quality & Safety
Providing safe nutritional products during the Coronavirus outbreak
Type: Blog
Topic(s): Quality & Safety
Donor Ashlee
Type: Donor Stories
Topic(s): Tiny Treasures
Banner - University Medicine Tucson Adopts Prolacta’s Exclusive Human Milk Diet
Type: Prolacta in the News
Topic(s): Hospital Experience
Donor Lydia
Type: Donor Stories
Topic(s): Tiny Treasures
Microbiome and gut-brain axis in premature infants focus of 2020 International Conference on Human Milk Science and Innovation
Type: Press Releases
Topic(s): Conferences and Events Microbiome
The story of Kai and Maryn, as told by their mom, Katie
Type: Donor Stories Parent Stories
Topic(s): 22-27 weeks (extremely premature)
The story of Charlie and Nathan, as told by their parents
Type: Parent Stories
Topic(s): 22-27 weeks (extremely premature)
